Moderna's Officer Stephen Hoge conducted multiple transactions on October 14 and October 15, 2026, selling a total of 78,369 shares of Moderna common stock. Additionally, he acquired 152,905 shares through the exercise of options. Executive stock sales are often seen as a signal that the company's current stock price may be overvalued, and investors should stay vigilant.